FDA Requests Removal of Suicidal Ideation Warning From GLP-1 RA Medications

JAMA 2026

View at publisher
Authors: Samantha Anderer
DOI: 10.1001/jama.2025.26370
Cited by: 4

Fields of Study & Subjects

Diabetes Treatment and Management Pharmacovigilance and Adverse Drug Reactions Medication Adherence and Compliance

Publication details

Journal / source
JAMA
Publisher
American Medical Association (AMA)
Volume
335
Issue
8
Pages
659–659
Publication date
30 January 2026
Language
EN